India will now be using a generic version of the Remdesivir drug that is administered intravenously. The Drug Controller General of India (DCGI) has approved its use to be launched under brand name Desrem. It will be for restricted emergency use in Covid-19 patients. This drug is in high demand after the intravenously-administered medicine has ...

India is seeing an increasing use of the medicines like Favipiravir, along with another antiviral, remdesivir by hospitals in the tackling of the Covid-19 virus. Looking at the increasing number of cases per day, Sun Pharmaceutical Industries is now coming out with its own version of Favipiravir called FluGuard that is to cost Rs. 35 ...